# Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma

> **NCT05869474** · NA · RECRUITING · sponsor: **Changhai Hospital** · enrollment: 206 (estimated)

## Conditions studied

- Metastatic Pancreatic Cancer

## Interventions

- **PROCEDURE:** Iodine125-Seeds implantation
- **DRUG:** Gem/nab-P Chemotherapy

## Key facts

- **NCT ID:** NCT05869474
- **Lead sponsor:** Changhai Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2023-08-01
- **Primary completion:** 2027-12
- **Final completion:** 2027-12
- **Target enrollment:** 206 (ESTIMATED)
- **Last updated:** 2023-08-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05869474

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05869474, "Implantation of iodine125-Seeds Combined With Chemotherapy in the Treatment of Metastatic Pancreatic Carcinoma". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT05869474. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*